
Precision Hematology Topics-in-Focus program
What is precision hematology?
Precision hematology is an integrated approach to diagnosing and treating blood disorders—particularly hematologic malignancies—by leveraging detailed molecular, genetic, and functional information about each patient’s disease.
It matches therapies more precisely to individual patients by uniting innovative clinical trial designs with cutting-edge diagnostics, such as:
- Advanced imaging
- Genetic profiling
- Drug-sensitivity testing
This field brings together physicians, scientists, and other key stakeholders across preclinical, translational, and clinical research. Through this collaboration, precision hematology aims to:
- Accelerate the discovery of new treatment strategies
- Refine therapeutic decision-making
- Improve outcomes for patients with blood cancers
Our program’s goals
Our Precision Hematology Topics-in-Focus program is designed to promote innovative concepts for diagnostics and innovative clinical trial designs which will feed into the clinical application of precision hematology.
The goal of the program is to create a European regulatory framework for precision hematology. By increasing awareness and providing education, guidelines, and policies, we can improve access to:
- Diagnostics
- Clinical research
- Treatment in malignant hematology
Useful materials
- EHA Position Paper on Personalized Treatment for Hematologic Diseases
- Precision Medicine in Hematology in 2021: Definitions, Tools, Perspectives, and Open Questions
- In Vitro Diagnostic Medical Devices Regulation (IVDR) Initiatives at EHA
- Preceptorship meeting
- Topic-in-Focus Research Grant
- Topic-in-Focus Bilateral Collaborative Grant
- Position papers on HemaSphere
- Guidelines